The cytochrome P450 pathway in angiogenesis and endothelial cell biology

Cancer and Metastasis Reviews

Volumn 30, Issue 3-4, 2011, Pages 541-555

  Fleming, Ingrid ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

Angiogenesis; Cytochrome P450; Remodeling; Soluble epoxide hydrolase; Vascular tone

Indexed keywords

ARACHIDONIC ACID; CYTOCHROME P450; EPOXIDE HYDROLASE; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR;

ANGIOGENESIS; CALCIUM TRANSPORT; CELL ADHESION; CELL LINE; CELL MEMBRANE; CELL PROLIFERATION; CYTOLOGY; ENDOTHELIUM; ENDOTHELIUM CELL; ENZYME ACTIVITY; GENE DELETION; HEART RATE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERPOLARIZATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PULMONARY HYPERTENSION; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; SMOOTH MUSCLE FIBER;

ANIMALS; CYTOCHROME P-450 ENZYME SYSTEM; EICOSANOIDS; ENDOTHELIAL CELLS; EPOXIDE HYDROLASES; HUMANS; LUNG; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC;

EID: 83855164059     PISSN: 01677659     EISSN: 15737233     Source Type: Journal    
DOI: 10.1007/s10555-011-9302-3     Document Type: Review

References (153)

1. M Fer Y Dreano D Lucas L Corcos JP Salaun F Berthou Y Amet 2008 Metabolism of eicosapentaenoic and docosahexaenoic acids by recombinant human cytochromes P450 Archives of Biochemistry and Biophysics 471 116 125 18206980 1:CAS:528:DC%2BD1cXislKktbc%3D
2. M VanRollins RC Baker HW Sprecher RC Murphy 1984 Oxidation of docosahexaenoic acid by rat liver microsomes Journal of Biological Chemistry 259 5776 5783 6232277 1:CAS:528:DyaL2cXktF2iu7o%3D
3. E Barbosa-Sicard M Markovic H Honeck B Christ DN Muller WH Schunck 2005 Eicosapentaenoic acid metabolism by cytochrome P450 enzymes of the CYP2C subfamily Biochemical and Biophysical Research Communications 329 1275 1281 15766564 1:CAS:528:DC%2BD2MXit1eqt7o%3D
4. A Konkel WH Schunck 2011 Role of cytochrome P450 enzymes in the bioactivation of polyunsaturated fatty acids Biochimica et Biophysica Acta (BBA) - Proteins & Proteomics 1814 210 222 1:CAS:528:DC%2BC3cXhsVygs7zN
5. B Lauterbach E Barbosa-Sicard MH Wang H Honeck E Kargel J Theuer ML Schwartzman H Haller FC Luft M Gollasch WH Schunck 2002 Cytochrome P450-dependent eicosapentaenoic acid metabolites are novel BK channel activators Hypertension 39 609 613 11882617 1:CAS:528:DC%2BD38Xhs1Wrsb0%3D
6. D Ye D Zhang C Oltman K Dellsperger HC Lee M VanRollins 2002 Cytochrome P450 epoxygenase metabolites of docosahexaenoate potently dilate coronary arterioles by activating large-conductance calcium-activated potassium channels Journal of Pharmacology and Experimental Therapeutics 303 768 776 12388664 1:CAS:528:DC%2BD38XotlCns7c%3D
7. C Morin M Sirois V Echave E Rizcallah E Rousseau 2009 Relaxing effects of 17(18)-EpETE on arterial and airway smooth muscles in human lung American Journal of Physiology. Lung Cellular and Molecular Physiology 296 L130 L139 18978038 1:CAS:528:DC%2BD1MXpsFCkuw%3D%3D
8. EL Liclican K Gronert 2010 Molecular circuits of resolution in the eye The Scientific World Journal 10 1029 1047 1:CAS:528:DC%2BC3cXht1CjtrrF
9. H Tian Y Lu SP Shah S Hong 2010 Novel 14S,21-dihydroxy-docosahexaenoic acid rescues wound healing and associated angiogenesis impaired by acute ethanol intoxication/exposure Journal of Cellular Biochemistry 111 266 273 20506249 1:CAS:528:DC%2BC3cXhtlSnt7rK
10. P McLennan P Howe M Abeywardena R Muggli D Raederstorff M Mano T Rayner R Head 1996 The cardiovascular protective role of docosahexaenoic acid European Journal of Pharmacology 300 83 89 8741170 1:CAS:528:DyaK28XitlCkurs%3D
11. M Hashimoto K Shinozuka S Gamoh Y Tanabe MS Hossain YM Kwon N Hata Y Misawa M Kunitomo S Masumura 1999 The hypotensive effect of docosahexaenoic acid is associated with the enhanced release of ATP from the caudal artery of aged rats Journal of Nutrition 129 70 76 9915878 1:CAS:528:DyaK1MXlslGitQ%3D%3D
12. JM Frenoux ED Prost JL Belleville JL Prost 2001 A polyunsaturated fatty acid diet lowers blood pressure and improves antioxidant status in spontaneously hypertensive rats Journal of Nutrition 131 39 45 11208936 1:CAS:528: DC%2BD3MXotVKlsg%3D%3D
13. EH Oliw J Bylund C Herman 1996 Bisallylic hydroxylation and epoxidation of polyunsaturated fatty acids by cytochrome P450 Lipids 31 1003 1021 8898299 1:CAS:528:DyaK28Xmt1Knsb8%3D
14. J Bylund T Kunz K Valmsen EH Oliw 1998 Cytochromes P450 with bisallylic hydroxylation activity on arachidonic and linoleic acids studied with human recombinant enzymes and with human and rat liver microsomes Journal of Pharmacology and Experimental Therapeutics 284 51 60 9435160 1:CAS:528:DyaK1cXltlCmsQ%3D%3D
15. J Bylund J Ericsson EH Oliw 1998 Analysis of cytochrome P450 metabolites of arachidonic and linoleic acids by liquid chromatography-mass spectrometry with ion trap MS Analytical Biochemistry 265 55 68 9866708 1:CAS:528: DyaK1cXnvFymtL4%3D
16. WB Campbell I Fleming 2010 Epoxyeicosatrienoic acids and endothelium-dependent responses Pflügers Archiv - European Journal of Pharmacology 459 881 895 1:CAS:528:DC%2BC3cXls1Wqsbw%3D
17. JK Beetham T Tian BD Hammock 1993 cDNA cloning and expression of a soluble epoxide hydrolase from human liver Archives of Biochemistry and Biophysics 305 197 201 8342951 1:CAS:528:DyaK3sXlvFynuro%3D
18. JW Newman C Morisseau TR Harris BD Hammock 2003 The soluble epoxide hydrolase encoded by EPXH2 is a bifunctional enzyme with novel lipid phosphate phosphatase activity Proceedings of the National Academy of Sciences of the United States of America 100 1558 1563 12574510 1:CAS:528:DC%2BD3sXhsFGkt78%3D
19. A Cronin S Mowbray H Durk S Homburg I Fleming B Fisslthaler F Oesch M Arand 2003 The N-terminal domain of mammalian soluble epoxide hydrolase is a phosphatase Proceedings of the National Academy of Sciences of the United States of America 100 1552 1557 12574508 1:CAS:528:DC%2BD3sXhsFGkt74%3D
20. AE Enayetallah A Luria B Luo HJ Tsai P Sura BD Hammock DF Grant 2008 Opposite regulation of cholesterol levels by the phosphatase and hydrolase domains of soluble epoxide hydrolase Journal of Biological Chemistry 283 36592 36598 18974052 1:CAS:528:DC%2BD1cXhsFWnsrfL
21. CJ Sinal M Miyata M Tohkin K Nagata JR Bend FJ Gonzalez 2000 Targeted disruption of soluble epoxide hydrolase reveals a role in blood pressure regulation Journal of Biological Chemistry 275 40504 40510 11001943 1:CAS:528:DC%2BD3MXhsFeqsQ%3D%3D
22. A Luria C Morisseau HJ Tsai J Yang B Inceoglu B De Taeye SM Watkins MM Wiest JB German BD Hammock 2009 Alteration in plasma testosterone levels in male mice lacking soluble epoxide hydrolase American Journal of Physiology, Endocrinology and Metabolism 297 E375 E383 1:CAS:528:DC%2BD1MXhtVahsbbO
23. AE Enayetallah DF Grant 2006 Effects of human soluble epoxide hydrolase polymorphisms on isoprenoid phosphate hydrolysis Biochemical and Biophysical Research Communications 341 254 260 16414022 1:CAS:528:DC%2BD28XoslyhtQ%3D%3D
24. KL Tran PA Aronov H Tanaka JW Newman BD Hammock C Morisseau 2005 Lipid sulfates and sulfonates are allosteric competitive inhibitors of the N-terminal phosphatase activity of the Mammalian soluble epoxide hydrolase Biochemistry 44 12179 12187 16142916 1:CAS:528:DC%2BD2MXot1WjsLk%3D
25. WJ Kovacs LM Olivier SK Krisans 2002 Central role of peroxisomes in isoprenoid biosynthesis Progress in Lipid Research 41 369 391 12121718 1:CAS:528:DC%2BD38Xltleku7s%3D
26. BD Przybyla-Zawislak PK Srivastava J Vazquez-Matias HW Mohrenweiser JE Maxwell BD Hammock JA Bradbury AE Enayetallah DC Zeldin DF Grant 2003 Polymorphisms in human soluble epoxide hydrolase Molecular Pharmacology 64 482 490 12869654 1:CAS:528:DC%2BD3sXlvVCnsLY%3D
27. B Keserü E Barbosa-Sicard RT Schermuly H Tanaka BD Hammock N Weissmann B Fisslthaler I Fleming 2010 Hypoxia-induced pulmonary hypertension: Comparison of soluble epoxide hydrolase deletion vs. inhibition Cardiovascular Research 85 232 240 19679679
28. WB Campbell D Gebremedhin PF Pratt DR Harder 1996 Identification of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factors Circulation Research 78 415 423 8593700 1:CAS:528:DyaK28XhtlWrtrc%3D
29. B Fisslthaler R Popp L Kiss M Potente DR Harder I Fleming R Busse 1999 Cytochrome P450 2C is an EDHF synthase in coronary arteries Nature 401 493 497 10519554 1:STN:280:DyaK1MvkslSnsQ%3D%3D
30. J Bauersachs R Popp M Hecker E Sauer I Fleming R Busse 1996 Nitric oxide attenuates the release of endothelium-derived hyperpolarizing factor Circulation 94 3341 3347 8989149 1:CAS:528:DyaK2sXkslSjtA%3D%3D
31. S Khojasteh S Prabhu J Kenny J Halladay A Lu 2011 Chemical inhibitors of cytochrome P450 isoforms in human liver microsomes: A re-evaluation of P450 isoform selectivity European Journal of Drug Metabolism and Pharmacokinetics 36 1 16 21336516 1:CAS:528:DC%2BC3MXisleqsbk%3D
32. J Passauer E Büssemaker G Lassig F Pistrosch J Fauler P Gross I Fleming 2003 Baseline blood flow and bradykinin-induced vasodilator responses in the human forearm are insensitive to the CYP 2C9 inhibitor sulfaphenazole Clinical Science (London, England) 105 513 518 1:CAS:528:DC%2BD3sXnsVyisLo%3D
33. J Passauer F Pistrosch G Lässig K Herbrig E Büssemaker P Gross I Fleming 2005 Nitric oxide- and EDHF-mediated arteriolar tone in uremia is unaffected by selective inhibition of vascular cytochrome P450 2C9 Kidney International 67 1907 1912 15840038 1:CAS:528:DC%2BD2MXktlyjsr8%3D
34. S Fichtlscherer S Dimmeler S Breuer R Busse AM Zeiher I Fleming 2004 Inhibition of cytochrome P450 2C9 improves endothelium-dependent, nitric oxide-mediated vasodilatation in patients with coronary artery disease Circulation 109 178 183 14662709 1:CAS:528:DC%2BD2cXis1ersA%3D%3D
35. T Hillig P Krustrup I Fleming T Osada B Saltin Y Hellsten 2003 Cytochrome P450 2C9 plays an important role in the regulation of exercise-induced skeletal muscle blood flow and oxygen uptake in humans Journal of Physiology (London) 546 307 314 1:CAS:528:DC%2BD3sXhsFWgtbs%3D
36. J Bellien M Iacob L Gutierrez M Isabelle A Lahary C Thuillez R Joannides 2006 Crucial role of NO and endothelium-derived hyperpolarizing factor in human sustained conduit artery flow-mediated dilatation Hypertension 48 1088 1094 17075035 1:CAS:528:DC%2BD28XhtFymt7fO
37. J Bellien R Joannides M Iacob P Arnaud C Thuillez 2006 Evidence for a basal release of a cytochrome-related endothelium-derived hyperpolarizing factor in the radial artery in humans American Journal of Physiology-Heart and Circulatory Physiology 290 H1347 H1352 16339823 1:CAS:528:DC%2BD28Xks1Snsr8%3D
38. D Fischer U Landmesser S Spiekermann D Hilfiker-Kleiner M Hospely M Muller R Busse I Fleming H Drexler 2007 Cytochrome P450 2C9 is involved in flow-dependent vasodilation of peripheral conduit arteries in healthy subjects and in patients with chronic heart failure European Journal of Heart Failure 9 770 775 17572144 1:CAS:528:DC%2BD2sXovFentbo%3D
39. MA Ozkor JR Murrow AM Rahman N Kavtaradze J Lin A Manatunga AA Quyyumi 2011 Endothelium-derived hyperpolarizing factor determines resting and stimulated forearm vasodilator tone in health and in disease Circulation 123 2244 2253 21555712 1:CAS:528:DC%2BC3MXmsVCrsbw%3D
40. GD Snyder UM Krishna JR Falck AA Spector 2002 Evidence for a membrane site of action for 14,15-EET on expression of aromatase in vascular smooth muscle American Journal of Physiology-Heart and Circulatory Physiology 283 H1936 H1942 12384472 1:CAS:528:DC%2BD38XovVOmtLs%3D
41. PY Wong KT Lin YT Yan D Ahern J Iles SY Shen RK Bhatt JR Falck 1993 14(R),15(S)-epoxyeicosatrienoic acid (14(R),15(S)-EET) receptor in guinea pig mononuclear cell membranes Journal of Lipid Mediators 6 199 208 8395243 1:CAS:528:DyaK3sXmt1aktbw%3D
42. PY Wong PS Lai JR Falck 2000 Mechanism and signal transduction of 14(R),15(S)-epoxyeicosatrienoic acid (14,15-EET) binding in guinea pig monocytes Prostaglandins & Other Lipid Mediators 62 321 333 1:CAS:528: DC%2BD3cXnsFOlu78%3D
43. PY Wong PS Lai SY Shen YY Belosludtsev JR Falck 1997 Post-receptor signal transduction and regulation of 14(R),15(S)-epoxyeicosatrienoic acid (14,15-EET) binding in U-937 cells Journal of Lipid Mediators and Cell Signalling 16 155 169 9246605 1:CAS:528:DyaK2sXkvFOjsr4%3D
44. 125I-14,15-epoxyeicosa-8(Z)- enoic acid Journal of Pharmacology and Experimental Therapeutics 324 1019 1027 18171909 1:CAS:528:DC%2BD1cXivVajs7Y%3D
45. 125Iodo-14,15- epoxyeicosa-5Z-enoic acid: A high affinity radioligand used to characterize the epoxyeicosatrienoic acid antagonist binding site Journal of Pharmacology and Experimental Therapeutics 331 1137 1145 19762546 1:CAS:528:DC%2BD1MXhsFaqsLjI
46. AA Spector AW Norris 2007 Action of epoxyeicosatrienoic acids on cellular function American Journal of Physiology. Cell Physiology 292 C996 C1012 16987999 1:CAS:528:DC%2BD2sXjsFeqs74%3D
47. M Abukhashim G Wiebe J Seubert 2011 Regulation of forskolin-induced cAMP production by cytochrome P450 epoxygenase metabolites of arachidonic acid in HEK293 cells Cell Biology and Toxicology 27 321 332 21519968 1:CAS:528:DC%2BC3MXhtFWktrfL
48. M Medhora J Daniels K Mundey B Fisslthaler R Busse ER Jacobs DR Harder 2003 Epoxygenase-driven angiogenesis in human lung microvascular endothelial cells American Journal of Physiology-Heart and Circulatory Physiology 284 H215 H224 12388259 1:CAS:528:DC%2BD3sXmvF2jtQ%3D%3D
49. C Yang YW Kwan AL-S Au CC-W Poon Q Zhang SW Chan SM-Y Lee GP-H Leung 2010 14,15-Epoxyeicosatrienoic acid induces vasorelaxation through the prostaglandin EP2 receptors in rat mesenteric artery Prostaglandins & Other Lipid Mediators 93 44 51 1:CAS:528:DC%2BC3cXpvV2htL4%3D
50. DJ Behm A Ogbonna C Wu CL Burns-Kurtis SA Douglas 2008 Epoxyeicosatrienoic acids function as selective, endogenous antagonists of native thromboxane receptors: Identification of a novel mechanism of vasodilation Journal of Pharmacology and Experimental Therapeutics 328 231 239 18836067
51. R Busse G Edwards M Feletou I Fleming PM Vanhoutte AH Weston 2002 EDHF: Bringing the concepts together Trends in Pharmacological Sciences 23 374 380 12377579 1:CAS:528:DC%2BD38XmvV2hsrY%3D
52. 2+ stores Biochemistry Journal 280 783 789 1:CAS:528:DyaK3MXmslKmtLc%3D
53. 2+ store depletion in human platelets is more susceptible to cytochrome P-450 inhibitors than receptor-mediated calcium entry Cell Calcium 13 553 564 1334809 1:CAS:528:DyaK38XmsV2jtbo%3D
54. UR Michaelis I Fleming 2006 From endothelium-derived hyperpolarizing factor (EDHF) to angiogenesis: epoxyeicosatrienoic acids (EETs) and cell signaling Pharmacology and Therapeutics 111 584 595 16380164 1:CAS:528:DC%2BD28Xns1Sksrc%3D
55. H Watanabe J Vriens J Prenen G Droogmans T Voets B Nilius 2003 Anandamide and arachidonic acid use epoxyeicosatrienoic acids to activate TRPV4 channels Nature 424 434 438 12879072 1:CAS:528:DC%2BD3sXls1aqsbs%3D
56. 2+ permeable cation channel TRPV4 by cytochrome P450 epoxygenases in vascular endothelium Circulation Research 97 908 915 16179585 1:CAS:528: DC%2BD2MXhtFCitr%2FE
57. AE Loot R Popp B Fisslthaler J Vriens B Nilius I Fleming 2008 Role of cytochrome P450-dependent transient receptor potential V4 activation in flow-induced vasodilatation Cardiovascular Research 80 445 452 18682435 1:CAS:528:DC%2BD1cXhtl2hurfK
58. 2+ signaling and hyperpolarization in endothelial cells Arteriosclerosis, Thrombosis, and Vascular Biology 27 2612 2618 17872452 1:CAS:528:DC%2BD2sXhtlahtLzF
59. 2/w-hydroxylase/20-HETE pathways Circulation Research 104 1399 1409 19443836 1:CAS:528:DC%2BD1MXntVymtrc%3D
60. Ca channels Circulation Research 97 1270 1279 16269659 1:CAS:528:DC%2BD2MXht1yjurbO
61. B Nilius J Vriens J Prenen G Droogmans T Voets 2004 TRPV4 calcium entry channel: A paradigm for gating diversity American Journal of Physiology. Cell Physiology 286 C195 C205 14707014 1:CAS:528:DC%2BD2cXhsFaku7Y%3D
62. AA Spector X Fang GD Snyder NL Weintraub 2004 Epoxyeicosatrienoic acids (EETs): Metabolism and biochemical function Progress in Lipid Research 43 55 90 14636671 1:CAS:528:DC%2BD3sXptVemtL4%3D
63. RL Widstrom AW Norris J Van Der Veer AA Spector 2003 Fatty acid-binding proteins inhibit hydration of epoxyeicosatrienoic acids by soluble epoxide hydrolase Biochemistry 42 11762 11767 14529287 1:CAS:528:DC%2BD3sXntlyksb4%3D
64. Y Liu Y Zhang K Schmelzer TS Lee X Fang Y Zhu AA Spector S Gill C Morisseau BD Hammock JY Shyy 2005 The antiinflammatory effect of laminar flow: The role of PPARg, epoxyeicosatrienoic acids, and soluble epoxide hydrolase Proceedings of the National Academy of Sciences of the United States of America 102 16747 16752 16267130 1:CAS:528:DC%2BD2MXht1KgsLzE
65. LA Cowart S Wei MH Hsu EF Johnson MU Krishna JR Falck JH Capdevila 2002 The CYP4A isoforms hydroxylate epoxyeicosatrienoic acids to form high affinity peroxisome proliferator-activated receptor ligands Journal of Biological Chemistry 277 35105 35112 12124379 1:CAS:528:DC%2BD38Xnt1Wgtb4%3D
66. X Fang S Hu T Watanabe NL Weintraub GD Snyder J Yao Y Liu JYJ Shyy BD Hammock AA Spector 2005 Activation of peroxisome proliferator-activated receptor a by substituted urea-derived soluble epoxide hydrolase inhibitors Journal of Pharmacology and Experimental Therapeutics 314 260 270 15798002 1:CAS:528:DC%2BD2MXmtVeju70%3D
67. X Fang S Hu B Xu G Snyder S Harmon J Yao, et al. 2006 14,15-Dihydroxyeicosatrienoic acid activates peroxisome proliferator activated receptor alpha American Journal of Physiology-Heart and Circulatory Physiology 290 55 63
68. Kip1 Journal of Biological Chemistry 278 29619 29625 12773534 1:CAS:528:DC%2BD3sXlvFOnsro%3D
69. D Wang T Hirase T Nitto M Soma K Node 2009 Eicosapentaenoic acid increases cytochrome P-450 2J2 gene expression and epoxyeicosatrienoic acid production via peroxisome proliferator-activated receptor g in endothelial cells Journal of Cardiology 54 368 374 19944311
70. BG Hoebel WF Graier 1998 11,12-Epoxyeicosatrienoic acid stimulates tyrosine kinase activity in porcine aortic endothelial cells European Journal of Pharmacology 346 115 117 9617761 1:CAS:528:DyaK1cXitVKitbY%3D
71. I Fleming B Fisslthaler UR Michaelis L Kiss R Popp R Busse 2001 The coronary endothelium-derived hyperpolarizing factor (EDHF) stimulates multiple signalling pathways and proliferation in vascular cells Pflügers Archiv - European Journal of Physiology 442 511 518 11510882 1:CAS:528: DC%2BD3MXkvFGitbk%3D
72. M Potente UR Michaelis B Fisslthaler R Busse I Fleming 2002 Cytochrome P450 2C9-induced endothelial cell proliferation involves induction of mitogen-activated protein (MAP) kinase phosphatase-1, inhibition of the c-Jun N-terminal kinase, and up-regulation of cyclin D1 Journal of Biological Chemistry 277 15671 15676 11867622 1:CAS:528:DC%2BD38Xjs1Wjs7g%3D
73. K Node Y Huo X Ruan B Yang M Spiecker K Ley DC Zeldin JK Liao 1999 Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids Science 285 1276 1279 10455056 1:CAS:528:DyaK1MXls1Siur0%3D
74. Y Deng ML Edin KN Theken RN Schuck GP Flake MA Kannon LM Degraff FB Lih J Foley JA Bradbury JP Graves KB Tomer JR Falck DC Zeldin CR Lee 2011 Endothelial CYP epoxygenase overexpression and soluble epoxide hydrolase disruption attenuate acute vascular inflammatory responses in mice The FASEB Journal 25 703 713 21059750 1:CAS:528:DC%2BC3MXhvFSmsbw%3D
75. I Fleming UR Michaelis D Bredenkötter B Fisslthaler F Dehghani RP Brandes R Busse 2001 Endothelium-derived hyperpolarizing factor synthase (cytochrome P450 2C9) is a functionally significant source of reactive oxygen species in coronary arteries Circulation Research 88 44 51 11139472 1:CAS:528:DC%2BD3MXosVOisQ%3D%3D
76. S Wu CR Moomaw KB Tomer JR Falck DC Zeldin 1996 Molecular cloning and expression of CYP2J2, a human cytochrome P450 arachidonic acid epoxygenase highly expressed in heart Journal of Biological Chemistry 271 3460 3468 8631948 1:CAS:528:DyaK28XhtFOksb0%3D
77. + channels and p42/p44 MAPK pathway Circulation Research 95 506 514 15256482 1:CAS:528:DC%2BD2cXntVCrtLo%3D
78. B Yang L Graham S Dikalov RP Mason JR Falck JK Liao DC Zeldin 2001 Overexpression of cytochrome P450 CYP2J2 protects against hypoxia-reoxygenation injury in cultured bovine aortic endothelial cells Molecular Pharmacology 60 310 320 11455018 1:CAS:528:DC%2BD3MXlsFansbY%3D
79. DC Zeldin J Foley J Ma JE Boyle JM Pascual CR Moomaw KB Tomer C Steenbergen S Wu 1996 CYP2J subfamily P450s in the lung: Expression, localization, and potential functional significance Molecular Pharmacology 50 1111 1117 8913342 1:CAS:528:DyaK28XntFCqsrs%3D
80. B Keserü E Barbosa-Sicard R Popp B Fisslthaler A Dietrich T Gudermann BD Hammock JR Falck N Weissmann R Busse I Fleming 2008 Epoxyeicosatrienoic acids and the soluble epoxide hydrolase are determinants of pulmonary artery pressure and the acute hypoxic pulmonary vasoconstrictor response The FASEB Journal 22 4306 4315 18725458
81. S Bonnet SL Archer 2007 Potassium channel diversity in the pulmonary arteries and pulmonary veins: Implications for regulation of the pulmonary vasculature in health and during pulmonary hypertension Pharmacology and Therapeutics 115 56 69 17583356 1:CAS:528:DC%2BD2sXntFyiur8%3D
82. D Zhu C Zhang M Medhora ER Jacobs 2002 CYP4A mRNA, protein, and product in rat lungs: Novel localization in vascular endothelium Journal of Applied Physiology 93 330 337 12070222 1:CAS:528:DC%2BD38XlsFOqsrs%3D
83. 2, and PI3-kinase/Akt American Journal of Physiology. Lung Cellular and Molecular Physiology 298 L564 L574 20061439 1:CAS:528:DC%2BC3cXkvVSjs7w%3D
84. D Zhu EK Birks CA Dawson M Patel JR Falck K Presberg RJ Roman ER Jacobs 2000 Hypoxic pulmonary vasoconstriction is modified by P-450 metabolites American Journal of Physiology-Heart and Circulatory Physiology 279 H1526 H1533 11009437 1:CAS:528:DC%2BD3cXns1ehtbc%3D
85. L Kiss Y Roder J Bier N Weissmann W Seeger F Grimminger 2008 Direct eicosanoid profiling of the hypoxic lung by comprehensive analysis via capillary liquid chromatography with dual online photodiode-array and tandem mass-spectrometric detection Analytical and Bioanalytical Chemistry 390 697 714 18080119 1:CAS:528:DC%2BD1cXis1Shtg%3D%3D
86. AH Stephenson RS Sprague AJ Lonigro 1998 5,6-Epoxyeicosatrienoic acid reduces increases in pulmonary vascular resistance in the dog American Journal of Physiology 275 H100 H109 9688901 1:CAS:528:DyaK1cXkvFaruro%3D
87. AH Stephenson RS Sprague JL Losapio AJ Lonigro 2003 Differential effects of 5,6-EET on segmental pulmonary vasoactivity in the rabbit American Journal of Physiology-Heart and Circulatory Physiology 284 H2153 H2161 12609822 1:CAS:528:DC%2BD3sXltVehs7s%3D
88. MA Miller CA Hales 1979 Role of cytochrome P-450 in alveolar hypoxic pulmonary vasoconstriction in dogs The Journal of Clinical Investigation 64 666 673 457876 1:CAS:528:DyaE1MXlt1WktL8%3D
89. P Pokreisz I Fleming L Kiss E Barbosa-Sicard B Fisslthaler JR Falck BD Hammock IH Kim Z Szelid P Vermeersch H Gillijns M Pellens F Grimminger AJ van Zonneveld D Collen R Busse S Janssens 2006 Cytochrome P450 epoxygenase gene function in hypoxic pulmonary vasoconstriction and pulmonary vascular remodeling Hypertension 47 762 770 16505204 1:CAS:528:DC%2BD28XitlSgtb8%3D
90. D Zhu M Bousamra DC Zeldin JR Falck M Townsley DR Harder RJ Roman ER Jacobs 2000 Epoxyeicosatrienoic acids constrict isolated pressurized rabbit pulmonary arteries American Journal of Physiology. Lung Cellular and Molecular Physiology 278 L335 L343 10666118 1:CAS:528:DC%2BD3cXhsVOgsbY%3D
91. N Weissmann A Dietrich B Fuchs H Kalwa M Ay R Dumitrascu A Olschewski U Storch M Schnitzler HA Ghofrani RT Schermuly O Pinkenburg W Seeger F Grimminger T Gudermann 2006 Classical transient receptor potential channel 6 (TRPC6) is essential for hypoxic pulmonary vasoconstriction and alveolar gas exchange Proceedings of the National Academy of Sciences of the United States of America 103 19093 19098 17142322 1:CAS:528:DC%2BD28Xhtlers7nP
92. KA Fagan M Oka NR Bauer SA Gebb DD Ivy KG Morris IF McMurtry 2004 Attenuation of acute hypoxic pulmonary vasoconstriction and hypoxic pulmonary hypertension in mice by inhibition of Rho-kinase American Journal of Physiology. Lung Cellular and Molecular Physiology 287 L656 L664 14977625 1:CAS:528:DC%2BD2cXptVyhs7k%3D
93. 2+ entry induces RhoA activation and resultant endothelial cell shape change in response to thrombin Journal of Biological Chemistry 282 7833 7843 17197445 1:CAS:528:DC%2BD2sXis1KgsLc%3D
94. JK Chen JR Falck KM Reddy J Capdevila RC Harris 1998 Epoxyeicosatrienoic acids and their sulfonimide derivatives stimulate tyrosine phosphorylation and induce mitogenesis in renal epithelial cells Journal of Biological Chemistry 273 29254 29261 9786938 1:CAS:528:DyaK1cXntlejsro%3D
95. JK Chen D-W Wang JR Falck J Capdevila RC Harris 1999 Transfection of an active cytochrome P450 arachidonic acid epoxygenase indicates that 14,15-epoxyeicosatrienoic acid functions as an intracellular messenger in response to epidermal growth factor Journal of Biological Chemistry 274 4764 4769 9988714 1:CAS:528:DyaK1MXhsFSmu7g%3D
96. DH Munzenmaier DR Harder 2000 Cerebral microvascular endothelial cell tube formation: Role of astrocytic epoxyeicosatrienoic acid release American Journal of Physiology-Heart and Circulatory Physiology 278 H1163 H1167 10749710 1:CAS:528:DC%2BD3cXislSlur0%3D
97. Y Wang X Wei X Xiao R Hui JW Card MA Carey DW Wang DC Zeldin 2005 Arachidonic acid epoxygenase metabolites stimulate endothelial cell growth and angiogenesis via mitogen-activated protein kinase and phosphatidylinositol 3-kinase/Akt signaling pathways Journal of Pharmacology and Experimental Therapeutics 314 522 532 15840765 1:CAS:528:DC%2BD2MXntVSju7g%3D
98. J-K Chen J Capdevila RC Harris 2002 Heparin-binding EGF-like growth factor mediates the biological effects of P450 arachidonate epoxygenase metabolites in epithelial cells Proceedings of the National Academy of Sciences of the United States of America 99 6029 6034 11983897 1:CAS:528: DC%2BD38XjslWgu7w%3D
99. UR Michaelis B Fisslthaler M Medhora D Harder I Fleming R Busse 2003 Cytochrome P450 2C9-derived epoxyeicosatrienoic acids induce angiogenesis via cross-talk with the epidermal growth factor receptor (EGFR) The FASEB Journal 17 770 772 12586744 1:CAS:528:DC%2BD3sXislGltLw%3D
100. A Pozzi I Macias-Perez T Abair S Wey Y Su R Zent JR Falk JH Capdevila 2005 Charaterization of 5,6-and 8,9-epoxyeicosatrienoic acids (5,6- and 8,9-EET) as potent in vivo angiogenic lipids Journal of Biological Chemistry 280 27138 27146 15917237 1:CAS:528:DC%2BD2MXmt1GgtL4%3D
101. HS Park MS Kim SH Huh J Park J Chung SS Kang EJ Choi 2002 Akt (protein kinase B) negatively regulates SEK1 by means of protein phosphorylation Journal of Biological Chemistry 277 2573 2578 11707464 1:CAS:528:DC%2BD38XhtVSgs7g%3D
102. RH Levy 1995 Cytochrome P450 isozymes and antiepileptic drug interactions Epilepsia 36 Suppl 5 S8 S13 8806399
103. UR Michaelis B Fisslthaler E Barbosa-Sicard JR Falck I Fleming R Busse 2005 Cytochrome P450 epoxygenases 2C8 and 2C9 are implicated in hypoxia-induced endothelial cell migration and angiogenesis Journal of Cell Science 118 5489 5498 16291720 1:CAS:528:DC%2BD28XjvFOhsA%3D%3D
104. AC Webler UR Michaelis R Popp E Barbosa-Sicard A Murugan JR Falck B Fisslthaler I Fleming 2008 Epoxyeicosatrienoic acids are part of the VEGF-activated signaling cascade leading to angiogenesis American Journal of Physiology. Cell Physiology 295 C1292 C1301 18787075 1:CAS:528: DC%2BD1cXhsVWkurjK
105. S Yang S Wei A Pozzi JH Capdevila 2009 The arachidonic acid epoxygenase is a component of the signaling mechanisms responsible for VEGF-stimulated angiogenesis Archives of Biochemistry and Biophysics 489 82 91 19464254 1:CAS:528:DC%2BD1MXhtFagurjP
106. SY Cheranov M Karpurapu D Wang B Zhang RC Venema GN Rao 2008 An essential role for SRC-activated STAT-3 in 14,15-EET-induced VEGF expression and angiogenesis Blood 111 5581 5591 18408167 1:CAS:528:DC%2BD1cXnsVOktL0%3D
107. A Oguro K Sakamoto S Suzuki S Imaoka 2009 Contribution of hydrolase and phosphatase domains in soluble epoxide hydrolase to vascular endothelial growth factor expression and cell growth Biological and Pharmaceutical Bulletin 32 1962 1967 19952412 1:CAS:528:DC%2BC3cXhsVOqs7o%3D
108. SS Gerety HU Wang ZF Chen DJ Anderson 1999 Symmetrical mutant phenotypes of the receptor EphB4 and its specific transmembrane ligand ephrin-B2 in cardiovascular development Molecular Cell 4 403 414 10518221 1:CAS:528:DyaK1MXmsVChsL8%3D
109. D Shin G Garcia-Cardena S Hayashi S Gerety T Asahara G Stavrakis J Isner J Folkman MA Gimbrone Jr DJ Anderson 2001 Expression of ephrinB2 identifies a stable genetic difference between arterial and venous vascular smooth muscle as well as endothelial cells, and marks subsets of microvessels at sites of adult neovascularization Developmental Biology 230 139 150 11161568 1:CAS:528:DC%2BD3MXnsFSitg%3D%3D
110. AC Webler R Popp T Korff UR Michaelis C Urbich R Busse I Fleming 2008 Cytochrome P450 2C9-induced angiogenesis is dependent on EphB4 Arteriosclerosis, Thrombosis, and Vascular Biology 28 1123 1129 18340006 1:CAS:528: DC%2BD1cXlsFOjur4%3D
111. SL Amaral KG Maier DN Schippers RJ Roman AS Greene 2003 CYP4A metabolites of arachidonic acid and VEGF are mediators of skeletal muscle angiogenesis American Journal of Physiology-Heart and Circulatory Physiology 284 H1528 H1535 12521947 1:CAS:528:DC%2BD3sXjvFGrtrw%3D
112. M Jiang A Mezentsev R Kemp K Byun JR Falck JM Miano A Nasjletti NG Abraham M Laniado-Schwartzman 2004 Smooth muscle-specific expression of CYP4A1 induces endothelial sprouting in renal arterial microvessels Circulation Research 94 167 174 14670847 1:CAS:528:DC%2BD2cXntlCisA%3D%3D
113. P Chen M Guo D Wygle PA Edwards JR Falck RJ Roman AG Scicli 2005 Inhibitors of cytochrome P450 4A suppress angiogenic responses American Journal of Pathology 166 615 624 15681843 1:CAS:528:DC%2BD2MXitVGmsLk%3D
114. AM Guo AS Arbab JR Falck P Chen PA Edwards RJ Roman AG Scicli 2007 Activation of vascular endothelial growth factor through reactive oxygen species mediates 20-hydroxyeicosatetraenoic acid-induced endothelial cell proliferation Journal of Pharmacology and Experimental Therapeutics 321 18 27 17210799 1:CAS:528:DC%2BD2sXktVSks7s%3D
115. J Sun XX Sui A Bradbury DC Zeldin MS Conte JK Liao 2002 Inhibition of vascular smooth muscle cell migration by cytochrome P450 epoxygenase-derived eicosanoids Circulation Research 90 1020 1027 12016269 1:CAS:528: DC%2BD38XjvFGksbw%3D
116. VY Ng Y Huang LM Reddy JR Falck ET Lin DL Kroetz 2007 Cytochrome P450 eicosanoids are activators of peroxisome proliferator-activated receptor α Drug Metabolism and Disposition 35 1126 1134 17431031 1:CAS:528: DC%2BD2sXns1yhsrc%3D
117. BB Davis DA Thompson LL Howard C Morisseau BD Hammock RH Weiss 2002
118. BB Davis C Morisseau JW Newman TL Pedersen BD Hammock RH Weiss 2006 Attenuation of vascular smooth muscle cell proliferation by 1-cyclohexyl-3- dodecyl urea is independent of soluble epoxide hydrolase inhibition Journal of Pharmacology and Experimental Therapeutics 316 815 821 16221742 1:CAS:528:DC%2BD28XhtlWqt7w%3D
119. M Revermann M Schloss E Barbosa-Sicard A Mieth S Liebner C Morisseau G Geisslinger RT Schermuly I Fleming BD Hammock RP Brandes 2010 Soluble epoxide hydrolase deficiency attenuates neointima formation in the femoral cuff model of hyperlipidemic mice Arteriosclerosis, Thrombosis, and Vascular Biology 30 909 914 20224052 1:CAS:528:DC%2BC3cXkslKru7c%3D
120. AN Simpkins RD Rudic S Roy HJ Tsai BD Hammock JD Imig 2009 Soluble epoxide hydrolase inhibition modulates vascular remodeling American Journal of Physiology-Heart and Circulatory Physiology 298 H795 H806 20035028
121. O Jung RP Brandes IH Kim F Schweda R Schmidt BD Hammock R Busse I Fleming 2005 Soluble epoxide hydrolase is a main effector of angiotensin II-induced hypertension Hypertension 45 759 765 15699457 1:CAS:528:DC%2BD2MXisV2jtbk%3D
122. C Vafeas PA Mieyal F Urbano JR Falck K Chauhan M Berman ML Schwartzman 1998 Hypoxia stimulates the synthesis of cytochrome P450-derived inflammatory eicosanoids in rabbit corneal epithelium Journal of Pharmacology and Experimental Therapeutics 287 903 910 9864271 1:CAS:528:DyaK1MXjvVShtQ%3D%3D
123. + channel current in cultured rat hippocampal astrocytes Neuroscience 143 703 716 17027168 1:CAS:528:DC%2BD28Xht1agt7%2FE
124. 12/13 and Rho-kinase activated by the angiotensin II type-1 receptor: Implication in vascular migration Arteriosclerosis, Thrombosis, and Vascular Biology 29 217 224 19095998 1:CAS:528:DC%2BD1MXlvFentw%3D%3D
125. AE Schultze RA Roth 1998 Chronic pulmonary hypertension-The monocrotaline model and involvement of the hemostatic system Journal of Toxicology and Environmental Health B 1 271 346 1:CAS:528:DyaK1cXmsFalt7c%3D
126. M Revermann E Barbosa-Sicard E Dony RT Schermuly C Morisseau G Geisslinger I Fleming BD Hammock RP Brandes 2009 Inhibition of the soluble epoxide hydrolase attenuates monocrotaline-induced pulmonary hypertension in rats Journal of Hypertension 27 322 331 19226702 1:CAS:528: DC%2BD1MXotVGnsg%3D%3D
127. C Zheng L Wang R Li B Ma L Tu X Xu RT Dackor DC Zeldin DW Wang 2010 Gene delivery of cytochrome P450 epoxygenase ameliorates monocrotaline-induced pulmonary artery hypertension in rats American Journal of Respiratory Cell and Molecular Biology 43 740 749 20118222 1:CAS:528:DC%2BC3cXhsF2jtr%2FE
128. T Yokose M Doy Y Taniguchi T Shimada M Kakiki T Horie Y Matsuzaki K Mukai 1999 Immunohistochemical study of cytochrome P450 2C and 3A in human non-neoplastic and neoplastic tissues Virchows Archiv 434 401 411 10389623 1:CAS:528:DyaK1MXjtVKrsL4%3D
129. JG Jiang CL Chen JW Card S Yang JX Chen XN Fu YG Ning X Xiao DC Zeldin DW Wang 2005 Cytochrome P450 2J2 promotes the neoplastic phenotype of carcinoma cells and is up-regulated in human tumors Cancer Research 65 4707 4715 15930289 1:CAS:528:DC%2BD2MXks1Ohtbs%3D
130. X Xu XA Zhang DW Wang 2011 The roles of CYP450 epoxygenases and metabolites, epoxyeicosatrienoic acids, in cardiovascular and malignant diseases Advanced Drug Delivery Reviews 63 597 609 21477627 1:CAS:528: DC%2BC3MXoslalur8%3D
131. C Chen G Li W Liao J Wu L Liu D Ma J Zhou RH Elbekai ML Edin DC Zeldin DW Wang 2009 Selective inhibitors of CYP2J2 related to terfenadine exhibit strong activity against human cancers in vitro and in vivo Journal of Pharmacology and Experimental Therapeutics 329 908 918 19289568 1:CAS:528:DC%2BD1MXms1ehur8%3D
132. AE Enayetallah RA French DF Grant 2006 Distribution of soluble epoxide hydrolase, cytochrome P450 2C8, 2C9 and 2J2 in human malignant neoplasms Journal of Molecular Histology 37 133 141 16957870 1:CAS:528:DC%2BD28XhtleksbjO
133. M Schmelzle L Dizdar H Matthaei SE Baldus J Wolters N Lindenlauf I Bruns RP Cadeddu F Kröpil SA Topp J Schulte am Esch II CF Eisenberger WT Knoefel NH Stoecklein 2011 Esophageal cancer proliferation is mediated by cytochrome P450 2C9 (CYP2C9) Prostaglandins & Other Lipid Mediators 94 25 33 1:CAS:528:DC%2BC3MXhtlaht7k%3D
134. JG Jiang YG Ning C Chen D Ma ZJ Liu S Yang J Zhou X Xiao XA Zhang ML Edin JW Card J Wang DC Zeldin DW Wang 2007 Cytochrome P450 epoxygenase promotes human cancer metastasis Cancer Research 67 6665 6674 17638876 1:CAS:528:DC%2BD2sXnslOjtbw%3D
135. C Chen X Wei X Rao J Wu S Yang F Chen D Ma J Zhou RT Dackor DC Zeldin DW Wang 2011 Cytochrome P450 2J2 is highly expressed in hematologic malignant diseases and promotes tumor cell growth Journal of Pharmacology and Experimental Therapeutics 336 344 355 21030485 1:CAS:528:DC%2BC3MXhslWhsrc%3D
136. R Mitra Z Guo M Milani C Mesaros M Rodriguez J Nguyen X Luo D Clarke J Lamba E Schuetz DB Donner N Puli JR Falck J Capdevila K Gupta IA Blair DA Potter 2011 CYP3A4 mediates growth of estrogen receptor-positive breast cancer cells in part by inducing nuclear translocation of phospho-Stat3 through biosynthesis of (±)-14,15-epoxyeicosatrienoic acid (EET) Journal of Biological Chemistry 286 17543 17559 21402692 1:CAS:528:DC%2BC3MXmtVGjtrs%3D
137. O Jung F Jansen A Mieth E Barbosa-Sicard RU Pliquett A Babelova C Morisseau SH Hwang C Tsai BD Hammock L Schaefer G Geisslinger K Amann RP Brandes 2010 Inhibition of the soluble epoxide hydrolase promotes albuminuria in mice with progressive renal disease PLoS One 5 e11979 20694143
138. JY Liu J Yang B Inceoglu H Qiu A Ulu SH Hwang N Chiamvimonvat BD Hammock 2010 Inhibition of soluble epoxide hydrolase enhances the anti-inflammatory effects of aspirin and 5-lipoxygenase activation protein inhibitor in a murine model Biochemical Pharmacology 79 880 887 19896470 1:CAS:528: DC%2BC3cXnvFGjsA%3D%3D
139. V Certikova Chabova A Walkowska E Kompanowska-Jezierska J Sadowski P Kujal Z Vernerova Z Vanourkova L Kopkan HJ Kramer JR Falck JD Imig BD Hammock I Vaneckova L Cervenka 2010 Combined inhibition of 20-hydroxyeicosatetraenoic acid formation and of epoxyeicosatrienoic acids degradation attenuates hypertension and hypertensioninduced end-organ damage in Ren-2 transgenic rats Clinical Science 118 617 632 20050826
140. YJ Chun S Kim 2003 Discovery of cytochrome P450 1B1 inhibitors as new promising anti-cancer agents Medicinal Research Reviews 23 657 668 12939788 1:CAS:528:DC%2BD3sXptlahsLs%3D
141. V Stearns MD Johnson JM Rae A Morocho A Novielli P Bhargava DF Hayes Z Desta DA Flockhart 2003 Active tamoxifen metabolite plasma concentrations after coadministration of tamoxifen and the selective serotonin reuptake inhibitor paroxetine Journal of the National Cancer Institute 95 1758 1764 14652237 1:CAS:528:DC%2BD3sXpvVelsbc%3D
142. JK Coller 2003 Oxidative metabolism of tamoxifen to Z-4-hydroxy-tamoxifen by cytochrome P450 isoforms: An appraisal of in vitro studies Clinical and Experimental Pharmacology and Physiology 30 845 848 14678248 1:CAS:528:DC%2BD3sXps1entr8%3D
143. D Panigrahy A Kaipainen E Greene S Huang 2010 Cytochrome P450-derived eicosanoids: The neglected pathway in cancer Cancer and Metastasis Reviews 29 723 735 20941528 1:CAS:528:DC%2BC3cXhtlant7%2FJ
144. Park, S. W., Heo, D. S. & Sung, M. W. (2011). The shunting of arachidonic acid metabolism to 5-lipoxygenase and cytochrome p450 epoxygenase antagonizes the anti-cancer effect of cyclooxygenase-2 inhibition in head and neck cancer cells. Cellular Oncology 1-8. doi: 10.1007/s13402-011-0051-7.
145. CN Serhan 2011 The resolution of inflammation: The devil in the flask and in the details The FASEB Journal 25 1441 1448 21532053 1:CAS:528: DC%2BC3MXlvFSmt7o%3D
146. MM Diaz Encarnacion GM Warner J Cheng CE Gray KA Nath JP Grande 2011 n-3 Fatty acids block TNF-a-stimulated MCP-1 expression in rat mesangial cells American Journal of Physiology. Renal Physiology 300 F1142 F1151 21367920
147. K Kitamura R Shibata Y Tsuji M Shimano Y Inden T Murohara 2011 Eicosapentaenoic acid prevents atrial fibrillation associated with heart failure in a rabbit model American Journal of Physiology-Heart and Circulatory Physiology 300 H1814 H1821 21335470
148. AA Finzi R Latini S Barlera MG Rossi A Ruggeri A Mezzani C Favero MG Franzosi D Serra D Lucci F Bianchini R Bernasconi AP Maggioni G Nicolosi M Porcu G Tognoni L Tavazzi R Marchioli 2011 Effects of n-3 polyunsaturated fatty acids on malignant ventricular arrhythmias in patients with chronic heart failure and implantable cardioverter-defibrillators: A substudy of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Insufficienza Cardiaca (GISSI-HF) trial American Heart Journal 161 338 343 21315217 1:CAS:528:DC%2BC3MXhvVyru7w%3D
149. C Arnold M Markovic K Blossey G Wallukat R Fischer R Dechend A Konkel C von Schacky FC Luft DN Muller M Rothe WH Schunck 2010 Arachidonic acid-metabolizing cytochrome P450 enzymes are targets of w-3 fatty acids Journal of Biological Chemistry 285 32723 32733
150. S Egert P Stehle 2011 Impact of n-3 fatty acids on endothelial function: results from human interventions studies Current Opinion in Clinical Nutrition and Metabolic Care 14 121 131 21252652 1:CAS:528:DC%2BC3MXhvV2ltrk%3D
151. J Madden CM Williams PC Calder G Lietz EA Miles H Cordell JC Mathers AM Minihane 2011 The impact of common gene variants on the response of biomarkers of cardiovascular disease (CVD) risk to increased fish oil fatty acids intakes Annual Review of Nutrition 31 203 234 21568708 1:CAS:528:DC%2BC3MXhtFais73J
152. HA Bazan Y Lu D Thoppil TN Fitzgerald S Hong A Dardik 2009 Diminished omega-3 fatty acids are associated with carotid plaques from neurologically symptomatic patients: Implications for carotid interventions Vascular Pharmacology 51 331 336 19733689 1:CAS:528:DC%2BD1MXhsVajtL%2FJ
153. Heinze, V. M., & Actis, A. B. (2011). Dietary conjugated linoleic acid and long-chain n-3 fatty acids in mammary and prostate cancer protection: A review. International Journal of Food Sciences and Nutrition. doi: 10.3109/09637486.2011.598849.